Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Barry Rost who wrote ()	11/9/1996 4:25:00 PM
From: Kris Dungan	of 1115

Lidak Pharmaceuticals 11077 N. Torrey Pines Rd.La Jolla, CA 92037 (619) 558-0364 Ticker: LDAKA Lidak Pharmaceuticals is a developmental stage company organized to engage in research, development, and commercialization of a patented, topical therapeutic product for viral and inflammatory skin disorders. For the nine months ended 6/30/96, revenues increased from $723K to $3.8M. Net loss decreased 74% to $1.9M. Results benefitted from $3M in license fee revenues earned in connection with certain license agreements.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext